These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Establishment of a cell line from a malignant rhabdoid tumor of the liver lacking the function of two tumor suppressor genes, hSNF5/INI1 and p16. Kuroda H; Moritake H; Sawada K; Kuwahara Y; Imoto I; Inazawa J; Sugimoto T Cancer Genet Cytogenet; 2005 Apr; 158(2):172-9. PubMed ID: 15796965 [TBL] [Abstract][Full Text] [Related]
3. Expression of pericyte, mesangium and muscle markers in malignant rhabdoid tumor cell lines: differentiation-induction using 5-azacytidine. Kato H; Ohta S; Koshida S; Narita T; Taga T; Takeuchi Y; Sugita K Cancer Sci; 2003 Dec; 94(12):1059-65. PubMed ID: 14662021 [TBL] [Abstract][Full Text] [Related]
5. [Smooth muscle myosin of SM1 and SM2 isoforms expressing human neuroblastoma cell line of MP-N-MS]. Sugimoto T; Komada Y; Sakurai M; Horii Y; Morishita R; Nagai R; Takahashi K; Asada Y Hum Cell; 1999 Mar; 12(1):47-56. PubMed ID: 10457905 [TBL] [Abstract][Full Text] [Related]
6. Malignant rhabdoid tumor shows a unique neural differentiation as distinct from neuroblastoma. Higashino K; Narita T; Taga T; Ohta S; Takeuchi Y Cancer Sci; 2003 Jan; 94(1):37-42. PubMed ID: 12708472 [TBL] [Abstract][Full Text] [Related]
7. Malignant rhabdoid tumor shows incomplete neural characteristics as revealed by expression of SNARE complex. Yoshida S; Narita T; Taga T; Ohta S; Takeuchi Y J Neurosci Res; 2002 Sep; 69(5):642-52. PubMed ID: 12210830 [TBL] [Abstract][Full Text] [Related]
8. Subcellular distribution of cytokeratin and vimentin in malignant rhabdoid tumor: three-dimensional imaging with confocal laser scanning microscopy and double immunofluorescence. Itakura E; Tamiya S; Morita K; Shiratsuchi H; Kinoshita Y; Oshiro Y; Oda Y; Ohta S; Furue M; Tsuneyoshi M Mod Pathol; 2001 Sep; 14(9):854-61. PubMed ID: 11557780 [TBL] [Abstract][Full Text] [Related]
9. Alpha-smooth-muscle actin and desmin expressions in human neuroblastoma cell lines. Sugimoto T; Ueyama H; Hosoi H; Inazawa J; Kato T; Kemshead JT; Reynolds CP; Gown AM; Mine H; Sawada T Int J Cancer; 1991 May; 48(2):277-83. PubMed ID: 2019470 [TBL] [Abstract][Full Text] [Related]
10. Establishment and molecular characterization of five cell lines derived from renal and extrarenal malignant rhabdoid tumors. Rosson GB; Hazen-Martin DJ; Biegel JA; Willingham MC; Garvin AJ; Oswald BW; Wainwright L; Brownlee NA; Wright CF Mod Pathol; 1998 Dec; 11(12):1228-37. PubMed ID: 9872656 [TBL] [Abstract][Full Text] [Related]
11. Malignant rhabdoid tumor. A study with two established cell lines. Ota S; Crabbe DC; Tran TN; Triche TJ; Shimada H Cancer; 1993 May; 71(9):2862-72. PubMed ID: 8385567 [TBL] [Abstract][Full Text] [Related]
12. Mutations of the p53 gene in malignant rhabdoid tumors of soft tissue and the kidney: immunohistochemical and DNA direct sequencing analysis. Kinoshita Y; Shiratsuchi H; Tamiya S; Oshiro Y; Hachitanda Y; Oda Y; Suita S; Tsuneyoshi M J Cancer Res Clin Oncol; 2001; 127(6):351-8. PubMed ID: 11414195 [TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of gefitinib in malignant rhabdoid tumor cells in vitro and in vivo. Kuwahara Y; Hosoi H; Osone S; Kita M; Iehara T; Kuroda H; Sugimoto T Clin Cancer Res; 2004 Sep; 10(17):5940-8. PubMed ID: 15355927 [TBL] [Abstract][Full Text] [Related]
14. Pediatric extra-renal rhabdoid tumors with unusual morphology: a diagnostic pitfall for small biopsies. Alaggio R; Boldrini R; Di Venosa B; Rosolen A; Bisogno G; Magro G Pathol Res Pract; 2009; 205(7):451-7. PubMed ID: 19243895 [TBL] [Abstract][Full Text] [Related]
15. Mutation analysis of human cytokeratin 8 gene in malignant rhabdoid tumor: a possible association with intracytoplasmic inclusion body formation. Shiratsuchi H; Saito T; Sakamoto A; Itakura E; Tamiya S; Oshiro Y; Oda Y; Toh S; Komiyama S; Tsuneyoshi M Mod Pathol; 2002 Feb; 15(2):146-53. PubMed ID: 11850543 [TBL] [Abstract][Full Text] [Related]
16. Expression of myosin isoforms in smooth muscle cells in the corpus cavernosum penis. DiSanto ME; Wang Z; Menon C; Zheng Y; Chacko T; Hypolite J; Broderick G; Wein AJ; Chacko S Am J Physiol; 1998 Oct; 275(4):C976-87. PubMed ID: 9755051 [TBL] [Abstract][Full Text] [Related]
17. Trastuzumab activates allogeneic or autologous antibody-dependent cellular cytotoxicity against malignant rhabdoid tumor cells and interleukin-2 augments the cytotoxicity. Katsumi Y; Kuwahara Y; Tamura S; Kikuchi K; Otabe O; Tsuchiya K; Iehara T; Kuroda H; Hosoi H; Sugimoto T Clin Cancer Res; 2008 Feb; 14(4):1192-9. PubMed ID: 18281554 [TBL] [Abstract][Full Text] [Related]
18. Expression of neural stem cell markers in malignant rhabdoid tumor cell lines. Okuno K; Ohta S; Kato H; Taga T; Sugita K; Takeuchi Y Oncol Rep; 2010 Feb; 23(2):485-92. PubMed ID: 20043111 [TBL] [Abstract][Full Text] [Related]
19. Argatroban, specific thrombin inhibitor, induced phenotype change of cultured rabbit vascular smooth muscle cells. Yoshinaga M; Sunagawa M; Shimada S; Nakamura M; Murayama S; Kosugi T Eur J Pharmacol; 2003 Feb; 461(1):9-17. PubMed ID: 12568910 [TBL] [Abstract][Full Text] [Related]
20. [A malignant rhabdoid tumor appearing simultaneously in the kidney and the brain of an infant: case report]. Morizane A; Nakahara I; Takahashi JA; Ishikawa M; Kikuchi H No Shinkei Geka; 1997 Jul; 25(7):665-9. PubMed ID: 9218263 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]